Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Sana Biotechnology
SANA
$1.06B
| $1.2M | ﹤0.01% |
295,100
+100,231
| +51% | +$369K |
|
2277
MillerKnoll
MLKN
$1.62B
| $1.2M | ﹤0.01% |
45,100
-93,083
| -67% | -$2.38M |
|
2278
Forum Energy Technologies
FET
$960M
| $1.2M | ﹤0.01% |
54,200
+2,025
| +4% | +$45.5K |
|
2279
F&G Annuities & Life
FG
$3.59B
| $1.2M | ﹤0.01% |
26,068
-21,932
| -46% | -$818K |
|
2280
Albany International
AIN
$1.84B
| $1.2M | ﹤0.01% |
12,200
-56,200
| -82% | -$4.9M |
|
|
QIPT
2281
DELISTED
Quipt Home Medical
QIPT
| $1.2M | ﹤0.01% |
235,324
+146,724
| +166% | +$703K |
|
2282
Tango Therapeutics
TNGX
$4.32B
| $1.2M | ﹤0.01% |
121,000
+82,800
| +217% | +$719K |
|
2283
Erie Indemnity
ERIE
$13.4B
| $1.2M | ﹤0.01% |
3,571
-85,500
| -96% | -$25.7M |
|
2284
James River Group Holdings
JRVR
$193M
| $1.2M | ﹤0.01% |
129,400
+31,602
| +32% | +$363K |
|
2285
Direxion Daily Small Cap Bear 3x ETF
TZA
$196M
| $1.19M | ﹤0.01% |
+5,980
| New | +$1.79M |
|
2286
Oxford Industries
OXM
$543M
| $1.19M | ﹤0.01% |
11,921
-14,600
| -55% | -$1.36M |
|
|
YMAB
2287
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.19M | ﹤0.01% |
174,800
-62,290
| -26% | -$360K |
|
2288
Dimensional International Small Cap Value ETF
DISV
$5.19B
| $1.19M | ﹤0.01% |
+46,200
| New | +$1.11M |
|
2289
Dimensional US Core Equity Market ETF
DFAU
$12.9B
| $1.19M | ﹤0.01% |
35,800
+17,000
| +90% | +$528K |
|
2290
LGL Group
LGL
$93.6M
| $1.19M | ﹤0.01% |
193,734
+1,500
| +0.8% | +$7.33K |
|
2291
Nurix Therapeutics
NRIX
$2.81B
| $1.19M | ﹤0.01% |
115,200
+88,400
| +330% | +$606K |
|
|
DOYU
2292
DouYu International Holdings
DOYU
$142M
| $1.19M | ﹤0.01% |
124,950
-650
| -0.5% | -$5.61K |
|
2293
MannKind Corp
MNKD
$1.24B
| $1.19M | ﹤0.01% |
326,045
-151,600
| -32% | -$579K |
|
2294
iShares ESG Optimized MSCI USA ETF
SUSA
$4.19B
| $1.19M | ﹤0.01% |
11,800
+4,200
| +55% | +$392K |
|
2295
Protalix BioTherapeutics
PLX
$179M
| $1.19M | ﹤0.01% |
665,600
+44,500
| +7% | +$69.2K |
|
|
ATSG
2296
DELISTED
Air Transport Services Group
ATSG
| $1.19M | ﹤0.01% |
67,300
-48,300
| -42% | -$859K |
|
2297
Schwab 1000 Index ETF
SCHK
$5.96B
| $1.18M | ﹤0.01% |
51,400
+21,800
| +74% | +$468K |
|
2298
APi Group
APG
$19B
| $1.18M | ﹤0.01% |
51,300
-446,550
| -90% | -$8.61M |
|
2299
Colony Bankcorp
CBAN
$473M
| $1.18M | ﹤0.01% |
88,978
+2,200
| +3% | +$23.8K |
|
|
CTV
2300
DELISTED
Innovid Corp.
CTV
| $1.18M | ﹤0.01% |
787,081
-4,831
| -0.6% | -$6.16K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.